AI 의료 영상 진단 시장 : 전략적 인사이트와 예측(2026-2035년)

The AI Medical Imaging Diagnostics Market is forecast to grow at a CAGR of 13.9%, reaching USD 34.18 billion in 2035 from USD 10.58 billion in 2026.

The global AI medical imaging diagnostics market is undergoing rapid transformation, driven by the convergence of rising imaging volumes, radiologist shortages, and the digital transformation of healthcare. This market provides software platforms and intelligent algorithms that analyze medical images to assist clinicians in detecting abnormalities, quantifying disease progression, and supporting evidence-based diagnosis. It supports hospitals, diagnostic imaging centers, and research institutions through automated image interpretation and workflow optimization. Demand is increasing as healthcare systems adopt digital imaging technologies, generating substantially larger and more complex datasets. Conventional interpretation workflows reduce reporting efficiency because radiologists must review increasingly complex examinations within constrained timelines. Solution providers are expanding deep learning, cloud computing, and multimodal AI platforms that improve diagnostic confidence while integrating seamlessly with picture archiving and communication systems (PACS) and radiology information systems (RIS). Regulatory oversight for Software as a Medical Device (SaMD), cybersecurity, and clinical validation continues to influence product development, as healthcare providers require trusted and clinically validated AI solutions.

Market Drivers

Rising Demand for Faster Diagnostic Imaging Interpretation

• Medical imaging plays a central role in disease diagnosis because clinicians increasingly depend on imaging findings to guide treatment decisions. Demand is shifting toward AI-powered diagnostics as hospitals process higher examination volumes across radiology departments. Manual interpretation creates reporting delays because growing patient demand increases radiologist workload while maintaining high diagnostic accuracy requirements. Technology developers are integrating deep learning algorithms, automated triage systems, and intelligent workflow management that accelerate image interpretation and prioritize critical findings. Faster diagnostic reporting improves clinical efficiency while supporting earlier therapeutic intervention.

Increasing Adoption of Artificial Intelligence in Radiology

• Artificial intelligence enhances radiology workflows because machine learning algorithms identify imaging patterns that support clinician interpretation across multiple disease areas. Demand is increasing as healthcare providers deploy AI solutions for chest imaging, oncology, cardiovascular diseases, neurology, and musculoskeletal imaging. Conventional image review limits scalability because radiologists must interpret increasingly complex multimodal examinations. Imaging technology companies are expanding computer vision, predictive analytics, and automated lesion detection capabilities that improve diagnostic consistency while reducing physician workload. AI-assisted interpretation strengthens healthcare quality by improving diagnostic confidence and workflow standardization.

Expansion of Precision Medicine and Quantitative Imaging

• Precision medicine depends on objective disease characterization because personalized treatment requires accurate assessment of anatomical and functional imaging biomarkers. Demand is growing for AI diagnostics as clinicians utilize quantitative image analysis to monitor disease progression and treatment response. Traditional qualitative image interpretation limits reproducibility because subtle imaging variations are difficult to quantify consistently. Solution providers are developing advanced imaging analytics, radiomics platforms, and multimodal AI that generate standardized clinical insights from complex datasets. Quantitative imaging strengthens personalized healthcare by supporting individualized clinical decision-making.

Growing Digital Transformation of Imaging Departments

• Healthcare digitalization increases dependence on intelligent imaging platforms because enterprise imaging ecosystems require seamless integration across multiple clinical systems. Demand is increasing as hospitals modernize PACS, RIS, and cloud-based imaging infrastructure. Legacy imaging environments restrict interoperability because fragmented workflows limit efficient access to diagnostic information. Technology providers are expanding cloud-native enterprise imaging, AI-enabled workflow automation, and interoperable healthcare platforms that improve operational efficiency and clinical collaboration. Digital transformation strengthens imaging services by enabling connected and data-driven diagnostic workflows.

Market Restraints

• Integration challenges between AI imaging software and existing PACS, RIS, and hospital information systems continue limiting enterprise-wide deployment. Regulatory requirements for clinical validation, algorithm transparency, and cybersecurity increase commercialization timelines. High implementation costs, limited reimbursement, and clinician concerns regarding algorithm reliability continue slowing adoption across smaller healthcare facilities.

Technology and Segment Insights

By Imaging Modality

• X-ray imaging represents one of the largest application areas because it serves as the primary modality for routine screening, emergency care, and musculoskeletal assessment. Hospitals are adopting AI to improve detection of fractures, pulmonary diseases, and chest abnormalities. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are significant segments driven by the complexity of cross-sectional imaging and the need for automated lesion detection and quantification. Ultrasound benefits from AI for workflow automation and image optimization. Nuclear imaging (PET/SPECT) and mammography are important segments for oncology and breast cancer screening, where AI enhances detection and risk assessment.

By Deployment Mode

• Cloud-based deployment is becoming the preferred model because healthcare organizations require centralized AI services across multiple facilities. Demand is increasing as enterprise imaging networks consolidate data to improve collaboration, scalability, and continuous software updates. Maintaining isolated on-premises infrastructure increases complexity because advanced AI applications require substantial computing resources. Technology providers are expanding secure cloud architectures and subscription-based delivery that simplify deployment. Cloud deployment enables healthcare organizations to scale AI diagnostics efficiently across distributed clinical environments.

By End User

• Hospitals represent the largest end-user segment because they perform high volumes of diagnostic imaging supporting emergency medicine, oncology, cardiology, and surgical planning. Demand is increasing as hospital networks integrate AI into enterprise imaging workflows to improve diagnostic accuracy and optimize radiology operations. Diagnostic imaging centers are expanding AI adoption to enhance efficiency and reporting consistency. Academic and research institutes contribute to algorithm development and clinical validation.

Competitive and Strategic Outlook

• The competitive landscape features major imaging equipment manufacturers and specialized AI software vendors. Siemens Healthineers AG differentiates itself by combining advanced imaging equipment with AI-enabled software, creating an integrated ecosystem supporting end-to-end radiology workflows. GE HealthCare Technologies Inc. maintains a competitive advantage through its Edison digital health ecosystem enabling AI across radiology. Koninklijke Philips N.V. integrates AI with diagnostic imaging, connected care, and healthcare informatics. Canon Medical Systems Corporation leverages its imaging expertise to expand AI capabilities. Fujifilm Holdings Corporation offers a diversified healthcare portfolio combining imaging systems and AI-driven analysis. Aidoc Medical Ltd. specializes in clinical AI solutions that identify and prioritize critical findings. Viz.ai, Inc. focuses on AI platforms that accelerate care coordination. IBM Corporation provides AI, cloud computing, and enterprise analytics infrastructure.
• Strategic developments include increasing integration of generative AI for report generation, expansion of cloud-based enterprise imaging, and development of AI for population screening programs. Companies are forming partnerships to enhance algorithm validation and clinical adoption. Product launches focus on FDA-cleared AI applications, workflow automation tools, and multimodal analytics platforms. Companies that successfully combine validated clinical performance with seamless workflow integration are expected to strengthen their competitive advantage.

Conclusion

• The AI medical imaging diagnostics market is poised for substantial growth, driven by rising imaging volumes, radiologist shortages, and the digital transformation of healthcare. The evolution from selective implementation toward routine clinical adoption across major healthcare systems is reshaping radiology practice. Companies that successfully deliver secure, interoperable, and clinically validated AI solutions are expected to lead the market. Ongoing technological innovation, regulatory support, and expanding digital health infrastructure will further accelerate adoption throughout the forecast period.

Key Benefits of this Report

• Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
• Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
• Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
• Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
• Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

• Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

• Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2035
• Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
• Competitive positioning, strategies, and market share evaluation, and trade analysis
• Revenue growth and forecast assessment across segments and regions
• Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. Executive Summary

• 1.1 Market Snapshot
• 1.2 Key Findings
• 1.3 Analyst Insights
• 1.4 Strategic Recommendations

2. Research Methodology

• 2.1 Research Design
• 2.2 Primary Research
• 2.3 Secondary Research
• 2.4 Market Size Estimation Methodology
• 2.5 Forecasting Model
• 2.6 Assumptions & Limitations

3. AI Medical Imaging Diagnostics Market Overview, Size & Forecast

• 3.1 Market Definition & Scope
• 3.2 Industry Overview
• 3.3 Industry Evolution
• 3.4 Market Size & Forecast (2021-2035)
• 3.5 Key Market Trends
• 3.6 AI Imaging Ecosystem Analysis
• 3.7 Imaging Workflow & AI Integration Analysis
• 3.8 AI Model Development & Clinical Validation Trends
• 3.9 Radiology Informatics & Enterprise Imaging Analysis
• 3.10 Precision Imaging & Predictive Diagnostics Trends

4. Market Dynamics

• 4.1 Market Drivers
• 4.2 Market Restraints
• 4.3 Market Opportunities
• 4.4 Market Challenges

5. Industry Landscape

• 5.1 Industry Value Chain Analysis
• 5.2 Supply Chain Analysis
• 5.3 Pricing Analysis
• 5.4 Porter's Five Forces Analysis
• 5.5 Healthcare AI Ecosystem Analysis

6. Innovation Landscape

• 6.1 Deep Learning in Medical Imaging
• 6.2 Computer Vision for Diagnostic Imaging
• 6.3 Generative AI in Medical Imaging
• 6.4 AI-Assisted Image Reconstruction
• 6.5 Cloud-Based Imaging Analytics
• 6.6 Explainable AI (XAI) in Diagnostics
• 6.7 Multimodal AI & Foundation Models for Medical Imaging

7. Regulatory Landscape

• 7.1 Global Regulatory Framework
• 7.2 AI-Based Software as a Medical Device (SaMD) Regulations
• 7.3 Medical Imaging Standards & Interoperability
• 7.4 AI Ethics, Data Privacy & Cybersecurity Regulations

8. AI Medical Imaging Diagnostics Market Landscape Analysis

• 8.1 Analysis by Imaging Modality
• 8.2 Analysis by Deployment Mode
• 8.3 Analysis by End User

9. AI Medical Imaging Diagnostics Market Segment Analysis (2021-2035)

• 9.1 By Imaging Modality
  • 9.1.1 X-ray
  • 9.1.2 Computed Tomography (CT)
  • 9.1.3 Magnetic Resonance Imaging (MRI)
  • 9.1.4 Ultrasound
  • 9.1.5 Nuclear Imaging (PET/SPECT)
  • 9.1.6 Mammography
• 9.2 By Deployment Mode
  • 9.2.1 Cloud-Based
  • 9.2.2 On-Premises
  • 9.2.3 Hybrid
• 9.3 By End User
  • 9.3.1 Hospitals
  • 9.3.2 Diagnostic Imaging Centers
  • 9.3.3 Academic & Research Institutes
  • 9.3.4 Ambulatory Surgical Centers (ASCs)
  • 9.3.5 Specialty Clinics

10. AI Medical Imaging Diagnostics Market Geographical Analysis (2021-2035)

• 10.1 North America
• 10.2 Europe
• 10.3 Asia Pacific
• 10.4 Latin America
• 10.5 Middle East & Africa

11. AI Medical Imaging Diagnostics Market Country Analysis (2021-2035)

• 11.1 United States
• 11.2 Canada
• 11.3 Germany
• 11.4 United Kingdom
• 11.5 France
• 11.6 Italy
• 11.7 Spain
• 11.8 Netherlands
• 11.9 Switzerland
• 11.10 China
• 11.11 Japan
• 11.12 India
• 11.13 South Korea
• 11.14 Australia
• 11.15 Brazil
• 11.16 Saudi Arabia
• 11.17 South Africa

12. Competitive Landscape

• 12.1 Market Share Analysis
• 12.2 Competitive Benchmarking
• 12.3 Strategic Developments
• 12.4 Mergers & Acquisitions
• 12.5 Partnerships & Collaborations
• 12.6 Product Launches & Regulatory Approvals

13. Company Profiles

• 13.1 Siemens Healthineers AG
• 13.2 GE HealthCare Technologies Inc.
• 13.3 Koninklijke Philips N.V.
• 13.4 Canon Medical Systems Corporation
• 13.5 Fujifilm Holdings Corporation
• 13.6 Aidoc Medical Ltd.
• 13.7 Viz.ai, Inc.
• 13.8 Qure.ai Technologies Pvt. Ltd.
• 13.9 Gleamer SAS
• 13.10 Lunit Inc.
• 13.11 Riverain Technologies
• 13.12 Nanox AI Ltd.
• 13.13 Arterys Inc.
• 13.14 Subtle Medical, Inc.
• 13.15 IBM Corporation

14. Commercial & Market Opportunity Analysis

• 14.1 AI Radiology Workflow Solutions
• 14.2 AI-Powered Image Analysis Platforms
• 14.3 Cloud-Based Medical Imaging AI Solutions
• 14.4 Enterprise Imaging Analytics Platforms
• 14.5 AI for Oncology Imaging Diagnostics
• 14.6 AI for Cardiovascular Imaging Diagnostics
• 14.7 AI for Neurology Imaging Diagnostics

15. Investment & Funding Analysis

• 15.1 Venture Capital & Private Equity Investments
• 15.2 Government Funding for AI in Healthcare
• 15.3 Research & Development Investments

16. Future Outlook

• 16.1 Emerging Market Opportunities
• 16.2 Future Technology Roadmap
• 16.3 Analyst Recommendations